A PHASE 1 STUDY OF SEA TGT (SGN-TGT) IN SUBJECTS WITH ADVANCED MALIGNANCIES

Registry ID

SGNTGT-001

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

SEAGEN INC.

Start date

2022-08-15

Completion date

2023-10-03

Last update

2021-06-08

Conditions

• ADVANCED MALIGNANT TUMORS

Related clinical trials

• A PHASE 1B/2 CLINICAL STUDY OF INTRATUMORAL ADMINISTRATION OF V937 IN COMBINATION WITH PEMRBOLIZUMAB (MK-3475) IN PARTICIPANTS WITH ADVANCED/METASTATIC SOLIC TUMORS
• A PHASE 1/2 FIRST-IN-HUMAN STUDY OF BMS-986288 ALONE AND IN COMBINATION WITH NIVOLUMAB IN ADVANCED MALIGNANT TUMORS

View on source registry